.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Farmers Insurance
Medtronic
Express Scripts
Harvard Business School
Dow
Colorcon
QuintilesIMS
Queensland Health

Generated: February 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: bupropion hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAKAISER FOUNDATION HOSPITALSN0179-0022-44
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAKAISER FOUNDATION HOSPITALSN0179-0022-88
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAKAISER FOUNDATION HOSPITALSN0179-0022-70
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAKAISER FOUNDATION HOSPITALSN0179-0030-70
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAActavis Pharma, Inc.N0591-3540-05
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAActavis Pharma, Inc.N0591-3540-60
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAActavis Pharma, Inc.N0591-3541-05
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAActavis Pharma, Inc.N0591-3541-25
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAActavis Pharma, Inc.N0591-3541-60
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095ANDAActavis Pharma, Inc.N0591-3542-60
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Baxter
Express Scripts
Farmers Insurance
Teva
Boehringer Ingelheim
Julphar
Citi
Fuji

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot